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Background: Tick and tsetse-borne diseases (TTBDs) constrain livestock production in tropical and subtropical
regions of the world. Of this community of endemic diseases, East coast fever (T.parva) is the most important
tick-borne disease (TBD) accounting for 70% of all losses due to TBDS in this region where control efforts target
either tsetse or TBDs and seldom both. In those instances where simultaneous pyrethroid insecticide TTBD control
is implemented, collateral benefits of tsetse control on TBD control have not been quantified. In the interest of
guiding future TTBD control efforts, the effect of restricting pyrethroid insecticides to the legs, belly and ears (RAP)
of cattle for tsetse and trypanosomiasis control on T.parva prevalence in crop-livestock production systems in Tororo
district, south-eastern Uganda was determined.
Methods: We randomly allocated 16 villages to diminazene diaceturate (DA) and 3 graded RAP (25%, 50% and 75%
of village herd sprayed respectively) treatment regimens. All cattle were ear-tagged, treated with diminazene
diaceturate (DA) and those in regimens 2-4 received monthly graded RAP. Blood samples taken fourteen days post
DA treatment and once three monthly were analysed by molecular techniques for T.parva.
Results: In total, 8,975 samples from 3,084 animals were analysed. Prevalence of T.parva varied between 1-3% in
different treatment regimens. RAP regimens were associated with slightly lower average risk of infection compared
to DA. However, the confidence interval was broad and the result was not statistically significant. There was no
evidence of a dose response relationship between graded RAP and T.parva prevalence. These findings are discussed
herein with regard to endemic stability development to different TBDs.
Conclusions: We found only a slight effect of RAP on T.parva infection. Since sample size determination was based
on trypanosomes incidence, the study was underpowered given the low T.parva prevalence. While the findings
need to be confirmed in future studies, the observed slight reduction in the risk of infection with T.parva might not
compromise endemic stability.
Keywords: Collateral benefits, Endemic stability, East coast fever, p104-based PCR, Restricted application protocol
(RAP), T.parva, Tororo district* Correspondence: luckydenno@covab.mak.ac.ug
1Department of Biomolecular and Biolaboratory Sciences, College of
Veterinary Medicine Animal Resources and Biosecurity, Makerere University,
P.O. Box 7062, Kampala, Uganda
2Division of pathway Medicine, Centre for Infectious Diseases, School of
Biomedical Sciences, College of Medicine and Veterinary Medicine, The
University of Edinburgh, Chancellor’s Building, 49 Little France Crescent,
Edinburgh EH16 4SB, UK
Full list of author information is available at the end of the article
© 2014 Muhanguzi et al.; licensee BioMed Cen
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Muhanguzi et al. Parasites & Vectors 2014, 7:432 Page 2 of 10
http://www.parasitesandvectors.com/content/7/1/432Background
Endemic hemoparasitic diseases of livestock mainly
TTBDs constrain livestock production in tropical and
subtropical regions of the world [1-3]. Of this commu-
nity of endemic vector-borne diseases; East coast fever
(ECF) caused by Theileria parva is the single most im-
portant TBD in the East African region costing about
70% of all losses due to TBDs [4-8]. Zoonotic trypano-
somiasis with a Reservoir in cattle population negatively
impacts on human health [9]. The cost of TTBDs to the
livestock sector is in form of mortality, morbidity, treat-
ment or control [4,6]. However, the importance of each
of these diseases cannot be singled out accurately as
they co-exist in the same livestock populations [5]. In
south-eastern Uganda, for example, TTBDs constrain
livestock populations and compound poverty levels,
with about 34% of all livestock holders subsisting on less
than 1.24 US$ per day [10-12]. In Sub-Saharan Africa,
veterinary services have largely been privatised and decen-
tralised [13-15] resulting in small holder farmers with in-
elastic budgets being largely in charge of disease control
programs [14-16]. To be beneficial and sustainable there
is a need for use of integrated livestock disease control
methods that are cheap and targeting more than one
endemic livestock disease. Livestock disease control
managers should therefore promote integrated low-cost
and environmentally sustainable technologies for TTBD
control [16,17].
A recent study in south-eastern Uganda, for example,
reported 62% of all farmers using amidines (Amitix® and
Noratraz®) for TBD control, which have no significant in-
secticidal activity to tsetse flies [18]. Similarly, donor and
government-led livestock disease control programs in this
area don’t always plan simultaneous TTBD control. How-
ever, these areas are endemic for AAT, acute HAT and
TBDs. In those tsetse control programmes designed to
benefit tick control, like in the stamp out sleeping sickness
(SOS) program in Uganda [19,20], the collateral benefits
of using pyrethroid insecticides for tsetse and trypano-
somiasis control on TBDs have, to our knowledge, not
been evaluated. In addition, the effect of simultaneous
TTBD control by use of pyrethroid insecticides by about
38% of the farmers in this region has not been assessed.
As such, benefits of simultaneous TTBD control by use of
pyrethroid insecticides have generally been evaluated only
in a few instances [21].
In order to prevent the merger of the chronic and
acute forms of HAT triggered by the northerly spread of
acute HAT caused by cattle restocking in south-eastern
Uganda, over 0.5 million cattle were sprayed by restricting
pyrethroid insecticides to the legs and bellies of cattle
[20,22]. This method otherwise called restricted applica-
tion of pyrethroid insecticides (RAP) has previously been
proved to be effective against tsetse and trypanosomiasis[17]. As such the SOS program used this technology to ef-
fectively control the merger of the two forms of sleeping
sickness triggered by cattle restocking in the north and
south-eastern Uganda following about 20 years of insur-
gence [19,20]. The said insurgence and the need to have
people in concentration camps led to loss of a large popu-
lation of cattle over the 20 year period. When people were
resettled in their former villages after the insurgence, the
government provided them with livestock (mainly cattle),
which was sourced from far south in the Busoga region
which is known to be endemic for T.b rhodesiense. As a
result, there was introduction of previously non-endemic
T.b rhodesiense into south-eastern Uganda especially Teso
region. This caused a northerly spread of T.b rhodesiense
facilitated by unregulated cattle trade and movement in
districts north of the Teso region.
In contrast to whole-body treatment, RAP has previ-
ously been reported as unlikely to disrupt endemic sta-
bility to TBDs [13,17]. This is thought to be as a result
of RAP maintaining a dampened exposure to tick-borne
pathogens as calves and development of solid immunity
against clinical disease as adults [23,24]. In crop-livestock
production systems where cattle are continuously exposed
to ticks [25,26], endemic stability is beneficial to reducing
losses due to TBDs. However, there is no much infor-
mation about the collateral benefit of using pyrethroid
insecticides for tsetse and trypanosomiasis control on
tick-borne hemoparasites populations. This study was
carried out to quantify the effect of applying RAP, which
is primarily used to control tsetse flies, on T.parva preva-
lence. We selected T.parva among other tick-borne hemo-
parasites because it is the causative agent of ECF, which
accounts for up to 70% of all livestock sector losses in the
region [4,7,27]. We further aimed at establishing if there
was any dose response relationship, by spraying varying
proportion of the village cattle herd. This information will
guide control managers and policy makers in planning
and evaluating simultaneous TTBD control programs and
to leverage resource allocation to human and livestock
vector-borne disease control programs.
Methods
Study area; study village selection and allocation to
treatment regimens
This study was carried out in Tororo District, south-
eastern Uganda between June 2012-December 2013. The
location, livestock production systems, climate and vege-
tation of Tororo District have been described elsewhere
[25,28]. Cattle herds of 16 villages were randomly allo-
cated to one of 4 different treatment regimens namely;
1) two treatments with diminazene diaceturate (DA) ad-
ministered at a dose of 0.01 g/kg live body weight (bwt) by
deep intramuscular injections at 40-day intervals (DA); 2)
DA and RAP of 25% of village herds; 3) DA and RAP of
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herds. Each of the regimens was trialed in 4 villages. We
screened 57 villages for eligibility and collected data on
basic socio-demographics, trypanosome and T.parva [28]
prevalence with molecular techniques. Twenty-seven vil-
lages fulfilled the eligibility criteria of i) a cattle population
of > =50 and ii) a trypanosome prevalence of > =15%. In
order to randomly select 16 villages, we generated 100
unique allocation sequences, which fulfilled the condition
of a minimum distance of 2 km between neighbouring
villages. This was to minimize contamination effects
from different intervention arms. Finally, one allocation
sequence was selected randomly.
Description of field cattle treatments
All cattle in the selected villages were ear tagged and
treated with a long acting diminazene diaceturate (DA)
containing cyanocobalamin (vitamin B12) and hydroxoco-
balamin (Vitamin B12a) (Veriben B12®; Ceva santé ani-
male, France), twice forty days apart at the beginning of
the trial. Veriben B12® was administered at a dose of
0.01 g/kg live body weight (bwt) by deep intramuscular in-
jections to rid cattle of trypanosome infections. Livestock-
keepers, their household particulars (village, parish, county)
and cattle demographics (age, sex, breed,) were entered on
a herd structure register at the time of introduction into
the intervention which was updated once three monthly.
In regimens 2-4; different proportions (25%, 50% and 75%)
of the village cattle herd were sprayed once every 28 days
in what is referred to here as graded RAP. An emulsifi-
able deltamethrin concentrate (Vectocid®, Ceva Inter-
chem, Tunis) spray was applied in the recommended
concentration of 1: 1000 (Vectocid to water parts) on
legs, belly and ears as previously described [17] for con-
trol of tsetse and ticks. Cattle in regimen 1 only received
two doses of DA forty days apart at the beginning of the
trial. Blood samples were taken 14 days post the last
Veriben B12® injection and repeated once three monthly
for 18 months of the trial. All cattle in the non-RAP vil-
lages were administered with Veriben B12® injections at
the end of the trial since they were at a higher risk of in-
fection with different trypanosome species.
Cattle blood sample collection
About 125 μl of blood were collected from the middle ear
vein and applied onto the classic Whatman FTA® cards
(Whatman Bioscience, Cambridge, UK) avoiding cross
contamination of the four samples on each card [29,30].
The samples were then allowed to air-dry, labelled with
cattle tag number, treatment regimen, sampling number,
village name, parish, sub County, County and date of col-
lection. They were packed in foil pouches with a silica gel
desiccant (Sigma Aldrich, Co., Life sciences, USA) prior to
shipping to the University of Edinburgh, UK for analysis.DNA extraction
DNA was extracted and eluted in Chelex®100 resin (Sigma
Aldrich, Co., Life sciences, USA) from 3 mm FTA test
sample or empty negative control discs according to a pre-
viously described protocol [30,31]. Eluted DNA samples
were kept at -20°C for long-term PCR analyses or 4°C if
they were to be analysed within a few days after extraction.
The Sources, quality and storage of DNA used as positive
control DNA for T.parva p104-based PCR [32] have been
recently described [28].
T.parva detection by kDa antigen (p104) based PCR
Eluted DNA samples were screened for T.parva using a
single pair of primers (IL4243; 5-GGC CAA GGT CTC
CTT CAG AAT ACG-3 and IL3232; 5-TGG GTG TGT
TTC CTC GTC ATC TGC-3) derived from p104 single
copy gene [32]. This primer set amplifies a 277 bp frag-
ment of a highly conserved segment of p104 gene making
it a very specific and sensitive target for T.parva diagnosis
[32,33]. The sensitivity and the choice for p104-based PCR
for T.parva detection have recently been discussed in our
previous study [28]. PCR was performed in a 25 μl reac-
tion volume; 20 μl of which was the PCR master mix con-
taining 2.55 μl of 10 x-reaction buffer (670 mM Tris-HCl
pH 8.8, 166 μM (NH4)2SO4, 4.5% Triton X-100, 2 mg/ml
gelatin) (Fisher Biotech), ImM MgCl2, 200 μM of each
dNTP, 5 μM each of the IL3232 and IL4234 primers, 0.7
U of BioTaq DNA polymerase (Fisher Biotech), 14.55 μl
RNase-free water and 5 μl of sample DNA or positive con-
trol DNA or negative control eluate [32,33]. PCR was
carried out in a DNA Engine Dyad® Cycler (PTC-0221,
Bio-Rad Laboratories Inc.) at cycling conditions including
a denaturation step at 95°C for 5 minutes, 30 cycles of de-
naturation at 94°C for 30 s each cycle, annealing at 65°C
for 30 s, extension at 72°C for 1 minute, final elongation
step at 72°C for 5 minutes [32,33]. PCR products were
electrophoresed in 1.5% agarose (Bio Tolls Inc. Japan),
stained in GelRed™ (Biotium, Inc., USA) and visualised on
an ultraviolet transilluminator.
Statistical analyses
The primary analysis investigated the impact of RAP on
the incidence risk ratios of T.parva infection using gen-
eralized linear mixed models with a Poisson distribution
and a logarithmic link function. To account for correl-
ation within clusters, villages were included as gamma
distributed random effects. The logarithm of time under
observation, i.e. the interval between the first and last
time an individual animal was sampled and included as
offset variable. To assess the intervention effect over
time, prevalences after 6, 12 and 18 months of follow up
were compared using mixed models with binary out-
come and logit link function. The original idea of model-
ling the proportion of animals treated with RAP as a
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did not observe decreasing infection risk with increasing
proportion of treated animals. Therefore, the results for
the different treatment regimens compared to the con-
trol regimen are presented. All statistical analyses were
performed using the R statistical software v 3.0.2 except
the Poisson random effect models, which were per-
formed in STATA v 12.1.Cattle biophysical monitoring data entry and analysis plan
Eight thousand nine hundred and seventy five (8,975)
blood samples were collected from 3,084 cattle, 1,625 of
which were introduced at the beginning of the trial and
1,459 were introduced during follow-up. Samples were
taken at seven sampling points; 14 days post last DA
treatment and there after once every three months for
18 months. The number of blood samples collected in
each of the four regimens, data entry and analysis plan
are summarised in Figure 1.Ethical clearance
This study was reviewed by the Makerere University
College of Veterinary Medicine Animal Resources and
Biosecurity ethical review board for compliance to Ani-
mal use and Care standards. It was then forwarded to
the Uganda National Council for Science and Technol-
ogy and approved under approval number HS1336.Figure 1 Study flow. Regimen 1: Diminazene diaceturate injections (DA);
Regimen 2: DA and 25% RAP. Regimen 3: DA and 50% RAP. Regimen 4: DA
first and last sampling of individual animals) was 12 months in each of theResults
Demographic characteristics 2 weeks post the second
diminazene treatment
One thousand six hundred and twenty seven cattle were
sampled 14 days post DA treatment in the 4 treatment reg-
imens and examined to determine T.parva prevalence.
Table 1 summarises the prevalence of T.parva in the 4 reg-
imens before and after treatment and the study population
demographic characteristics namely age, sex and breed.
Prevalence of T.parva by treatment regimen and time
The prevalence of T.parva about 9 months before initial
treatment in different regimens varied greatly from 2.4-
8.3%. At 14 days post DA injections (denoted as time 0),
T.parva prevalence dropped to 1.5% with the rate of fall
proportional to the baseline prevalence in all regimens.
Thereafter, T.parva prevalence slightly increased in all reg-
imens up to month 9 of the trial but prevalence remained
below 5%. In regimen 1, T.parva prevalence continued to
decline 3 months post DA administration up to 3 months
of the trial and there after increased up to 12 months of
the trial. In all regimens there was a general decrease in
T.parva prevalences from 12 months of the trial corre-
sponding to the reduction in the number of animals in
the trial. The prevalence of T.parva only reached pre-
intervention levels in regimen 3 at month 9 up to month
15. In the rest of the regimens including DA regimen
the prevalence of T.parva fluctuated at levels below the
pre-intervention levels (Figure 2).(0.01 g/kg body weight) forty days apart at the beginning of the trial.
and 75% RAP. Median time of follow up-FU (time difference between
4 treatment groups.
Table 1 Baseline characteristics of the study population (2 weeks after initial treatment)
Prevalence Treatment groups
1 2 3 4
A) Infection status 9 months before treatment and 2 weeks after initial treatment
Number sampled (n) 408 320 467 432
n villages 4 4 4 4
Prevalence before treatment [%]* 7.5 4.4 2.4 8.3
Prevalence after treatment [%] 1.0 1.6 1.7 2.1
B) Demographic characteristics
Population attributes n (% Within group)
Sex [n (%)]
Male 175 (43%) 109 (34%) 165 (35%) 176 (41%)
Female 192 (47%) 193 (60%) 269 (58%) 226 (52%)
Castrate 41 (10%) 18 (6%) 33 (7%) 30 (7%)
Breed [n (%)]
Boran × African short horn Zebu (Nkedi) 394 (97%) 296 (92%) 450 (96%) 423 (98%)
Boran × Holstein Friesian 8 (2%) 23 (7%) 0 (0%) 3 (1%)
African short horn Zebu (Nkedi) 6 (1%) 1 (0%) 17 (4%) 6 (1%)
Age in years [n (%)]
0.0-1.0 48 (12%) 40 (12%) 35 (7%) 72 (17%)
1.1-3.0 188 (46%) 153 (48%) 188 (40%) 150 (35%)
3.1+ 172 (42%) 127 (40%) 244 (52%) 210 (49%)
*determined 12 months before treatment (n = 321, 430, 572, 576).
Figure 2 T.parva prevalence by time in different regimens. Lines represent prevalences calculated as unweighted mean of the 4
village prevalences.
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time
Drop-in effect (cattle introductions) during follow-up did
not have any effect on T.parva prevalence up until month
9 of the trial where dilution effect of about 0.01 units on
the infection levels was observed mainly in regimens 1
and 4. Drop-in effect had a particularly high dilution effect
of 0.04 units on T.parva prevalence in regimen 2 at end of
the trial (Month 18). Table 2 summarises T.parva preva-
lence in each regimen over time with and with -out drop-
in effects at each sampling time.
Six monthly incidences and T.parva point prevalence in
RAP and non-RAP regimens
The proportion of positive samples was 2.1% slightly higher
in non-RAP compared to 1.8% in the RAP regimens butTable 2 Overall prevalence of T.parva in different
treatment regimens over an 18 months follow-up period
Regimen Month n T.parva n* T.parva*
1 0 408 0.01 408 0.01
2 317 0.02 317 0.02
3 467 0.00 467 0.00
4 433 0.02 433 0.02
1 3 273 0.00 268 0.00
2 294 0.02 294 0.02
3 415 0.01 414 0.01
4 355 0.02 338 0.02
1 6 359 0.03 316 0.03
2 308 0.02 264 0.02
3 375 0.01 326 0.01
4 361 0.03 309 0.04
1 9 307 0.04 257 0.05
2 299 0.04 231 0.04
3 383 0.01 259 0.01
4 320 0.03 226 0.04
1 12 404 0.04 331 0.04
2 285 0.03 186 0.03
3 426 0.02 297 0.02
4 353 0.03 230 0.04
1 15 169 0.04 150 0.03
2 234 0.02 124 0.02
3 270 0.03 148 0.01
4 264 0.02 136 0.03
1 18 198 0.01 173 0.01
2 210 0.03 90 0.07
3 262 0.02 117 0.01
4 226 0.02 128 0.02
*Only animals that received baseline treatment are included.the difference was not statistically significant (Incidence
Risk Ratio (IRR)=0.6; 95%CI; 0.22-1.67; P=0.65) as sum-
marised in Table 3. Similarly, the risk of infection with
T.parva was slightly higher in non-RAP than RAP vil-
lages at 6 and 12 months of the trial but this difference
was not significant (OR = 0.7 at each sampling time).
The risk of infection was higher in RAP than non-RAP
villages by 18 months of the trial (OR, 2.7; 95% CI; 0.37-
12.73) as summarised in Table 3.
Spatial effect on T.parva prevalence in different regimens
over time
T.parva prevalence was highly variable at each of the
seven sampling points in the four treatment groups
(Table 2). Moderate to high (5-10%) T.parva prevalences
were randomly distributed in the north, north-eastern
and the south-eastern parts of the district regardless of
treatment regimens (Figure 3).
Discussion
A randomized controlled trial was carried out in Tororo
District to determine the effect of applying RAP for tsetse
control on T.parva prevalence and how it would change
(if at all) with increasing RAP herd coverage. One thou-
sand six hundred and twenty five cattle were introduced
into one Non-RAP regimen and three graded RAP (25%,
50% and 75% herd coverage) regimens. About the same
number of cattle (1,459) was introduced in the four regi-
mens during the 18 months of follow-up.
At the beginning of the trial, 47% of all cattle were fe-
males while 46% of all cattle were above 3 years of age.
Such population structure of retaining more old cattle
with a female to male (whole and neutered males) ratio
of nearly 1 has previously been seen as a drive to creating
a mass of draught power animals [28,34]. This implies that
improving livestock health by controlling TTBDs will help
farmers use draught power, cattle manure and integrate
crop and livestock production thereby reducing poverty
and hunger [2,13,35-37].
T.parva prevalence varied greatly in different regimens
before (2.4-8.3%) the intervention. Medium to high (4.0-
7.0%) T.parva prevalence was observed persistently in vil-
lages in the north, north-eastern and the south-eastern
parts of the district (Figure 3) regardless of the treatment
regimen. This was previously associated with the differ-
ences in tick challenge between different intervention vil-
lages with T.parva prevalence proportional to the level of
tick challenge in each intervention village [28,38]. RAP
herd coverage was not associated with a proportionate de-
crease in T.parva prevalence probably as a result of village
level effect of differences in tick abundance and T.parva
transmission [28,38].
Other village level effects could have contributed to this
dose- response relationship distortion albeit in unknown
Table 3 T.parva incidence during 18 months of follow-up
Category Animals (n) Samples (n) Episodes (n) Positive (%) IRR 95% CI P
A) Overall incidences
No RAP 666 2118 45 2.1 Ref
RAP 2418 6857 121 1.8 0.80 0.30-2.14 0.65
B) Prevalences at month 6, 12 and 18
Animals; n (%) Positive; n (%) Crude OR 95% CI
i) Prevalence at month 6
No RAP 359 10 (3%) Ref
RAP 1044 21 (2%) 0.70 0.27-1.8
ii) Prevalence at month 12
No RAP 404 14 (3%) Ref
RAP 1064 29 (3%) 0.67 0.24-1.91
iii) Prevalence at month 18
No RAP 198 2 (1%) Ref
RAP 698 15 (2%) 2.17 0.37-12.73
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infections post DA injections, farming practices including
differences in veterinary care between villages and drop-in
effects; to a very little extent after 9 months into the trial.
There was a drastic decline in T.parva prevalence
14 days post DA treatment much as DA is not specificallyFigure 3 Spatial distribution of T.parva over an 18 months period. Th
the number of animals sampled.and routinely used in the treatment of T.parva infections.
The reason for this decline in the T.parva prevalence in
cattle post DA treatment could be 2 fold.
DA has previously been known to have some action on
members of the class Piroplasmida (Babesia, Theileria, and
Cytauxzoon) in addition to the primary targets for thise colour represents the prevalences. The circle area is proportional to
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Uganda where TTBDs are endemic, mixed infections with
Babesia, Anaplasma, Theileria and trypanosomes are com-
mon. These infections are usually associated with marked
anaemia and lethargy [40]. Veriben B12® contains vitamins
B12 and B12a which alleviate anaemia in addition to hav-
ing specific effect on trypanosomes, Anaplasma and Babe-
sia species. Therefore, the second plausible explanation of
the decline in the pre-intervention T.parva prevalence
2 weeks post Veriben B12® treatment is self-cure following
alleviation of anaemia and cleaning animals of concurrent
tsetse and other tick-borne infections.
The risk of infection and therefore the prevalence of
T.parva was lower in RAP regimens (2-4) than the DA
treatment regime. However, the incidence rate ratios as-
sociated with RAP and non RAP regimens were not sta-
tistically significant. Due to the generally low prevalence
of T.parva the study was underpowered, since sample
size determination was based on trypanosomiasis infec-
tion, which occurred at higher prevalences of about 30%
[41]. The prevalence of T.parva was only higher in RAP
regimens than regimen 1 only at month 18 of the trial.
This is likely to have been caused by the decline in ani-
mal population and drop-in effect (cattle introduction)
or simply by stochastic effects since the overall number
of positive animals was 18. Previously, it had been sug-
gested that restricting pyrethroid insecticides/acaracides
was likely to reduce tick populations and maintain a small
force of infection with tick-borne hemoparasites in cattle
[17,42]. We found only a slight effect of RAP on T.parva
infection, which is in line with this school of thought.
Since sample size determination was based on trypano-
some incidence, the study was underpowered given the
low T.parva prevalence. While the findings need to be
confirmed in future studies, the observed reduction in
the risk of infection with T.parva might not compromise
the endemic stability as had been previously suggested.
Restricted application of pyrethroid insecticides was
applied once every 28 days; an application regime that is
longer than what is recommended for three host tick
R. appendiculatus but sufficient for tsetse control [13].
This could have maintained a small population of ticks
on cattle there by maintaining a small prevalence of
T.parva in all regimens across over the follow-up time.
This in itself varied greatly in different villages as has
been explained depending on the variation in tick-
abundance in different villages as previously observed
[28,38]. This reaffirms that use of RAP is likely to main-
tain endemic stability in an epidemiological situation
that is beneficial in small holder crop-livestock produc-
tion systems like in south-eastern Uganda where cattle
are constantly exposed to ticks and therefore tick-borne
infections [25,26]. This, together with the fact that RAP is
environmentally benign have been reported as some ofthe collateral benefits of this technology [17,43]. RAP
uses about 20% of total amount of pyrethroid insecti-
cides compared to the amounts needed for whole body
spray [17,44]. This minimises damage to the invertebrate
dung fauna, which break down dung and add manure to
soils in crop-livestock production systems [45,46]. Our
findings that RAP had a slight effect on T.parva infection
indicating that it might not compromise endemic stability
to T.parva further proves that RAP is a promising future
farmer- based technique for simultaneous TTBD control
after more field based evaluations [17,42].
However, this should be extended to the possibility of
RAP maintaining endemic stability to other TBDs with
care because the ease with which endemic stability is
likely to develop to each TBD is different [13]. The prob-
ability of clinical disease development following infection
with different tick-borne hemoparasites, for example,
varies greatly with age [47-49]. Whereas less severe dis-
ease is likely to develop in calves below 6 months of age
in anaplasmosis, babesiosis and cowdriosis as a result of
maternal immunity in this age group, this relationship is
less pronounced in T.parva infections [13,50]. However,
this phenomenon is very important in ECF epidemiology.
Further studies are therefore recommended to investigate
the effect of RAP for tsetse and trypanosomiasis control
on seroconversion and/or progression to different tick-
borne clinical diseases. This will further broaden our
understanding of how RAP is likely to affect endemic sta-
bility to different TBDs in different livestock production
systems under different tick challenge levels.
Conclusions
We found only a slight effect of RAP on T.parva infection.
Since sample size determination was based on trypa-
nosomes incidence, the study was underpowered given
the low T.parva prevalence. While the findings need to be
confirmed in future studies, the observed reduction in
the risk of infection with T.parva might not compromise
endemic stability to T.parva infections. However, this should
be extended to the possibility of endemic stability develop-
ment to other TBDs reservedly since the ease with which
endemic stability develops to each TBD varies greatly. We
therefore recommend that future studies to investigate the
effect of RAP on sero-conversion and/ or progression to
clinical disease due to different tick-borne hemoparasites be
carried out in different livestock productions systems. This
research discourse is recommended because endemic stabil-
ity is important in reducing losses to TBDs in production
systems where cattle are continuously exposed to ticks with
very high force of infection of tick-borne hemoparasites.
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